Due to health issues, this site is no longer maintained and will be shut down shortly. |
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
$8.15 +0.14 (1.75%)
As of 03/27/2023 14:04:22 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.